Eli Lilly partners with AI-focused Genetic Leap to develop RNA-based drugs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/27/2026

1. NVDA
2. OKTA
3. CRM
4. CRWD
5. VEEV
6. KKR
7. P
8. NTNX
9. HPQ
10. A

Go back to Eli Lilly partners with AI-focused Genetic Leap to develop RNA-based drugs
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1189.41 --0 (-0%)
Previous Close $1189.41    52 Week High $88.16 
Open $1189.41    52 Week Low $67.88 
Day High $1189.41    P/E 275.33 
Day Low $1189.41    EPS $4.32 
Volume 10,138